Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
26.07
+2.37 (10.00%)
Aug 8, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Intermediates and Raw Materials | 747.07M | Log In | Log In | Log In | Log In | Upgrade |
Intermediates and Raw Materials Growth | 9.72% | Log In | Log In | Log In | Log In | Upgrade |
Preparation | 220.93M | Log In | Log In | Log In | Log In | Upgrade |
Preparation Growth | -0.74% | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Organization | 200.52M | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Organization Growth | -60.23% | Log In | Log In | Log In | Log In | Upgrade |
Trading | 40.18M | Log In | Log In | Log In | Log In | Upgrade |
Trading Growth | 25.65% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 7.79M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | -55.14% | Log In | Log In | Log In | Log In | Upgrade |
Medicine Circulation | - | Log In | Log In | Log In | Log In | Upgrade |
Medicine Circulation Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Hypotension | - | Log In | Log In | Log In | Log In | Upgrade |
Hypotension Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Central Nervous System | - | Log In | Log In | Log In | Log In | Upgrade |
Central Nervous System Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Antithrombic | - | Log In | Log In | Log In | Log In | Upgrade |
Antithrombic Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Hypolipidemic | - | Log In | Log In | Log In | Log In | Upgrade |
Health Lipids | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Overseas | 733.79M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 39.27% | Log In | Log In | Log In | Log In | Upgrade |
China | 474.91M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -47.97% | Log In | Log In | Log In | Log In | Upgrade |